Zhen Su - Aug 31, 2023 Form 3 Insider Report for Karyopharm Therapeutics Inc. (KPTI)

Role
Director
Signature
/s/Nancy Smith as Attorney-in-Fact for Zhen Su
Stock symbol
KPTI
Transactions as of
Aug 31, 2023
Transactions value $
$0
Form type
3
Date filed
9/1/2023, 08:17 AM
Next filing
Mar 22, 2024

No securities are beneficially owned.

Remarks:

No securities are beneficially owned.